CIK: 1704317 - Address: C/O Revance Therapeutics, Inc., 1222 Demonbreun Street, 20Th Floor, Nashville, TN 37203
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/14/19 17:49
3/12/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsCoric VladCTDOCEOS.m-5,00950.090-100-42,334I
6/1/18 17:26
5/30/18
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsCoric VladCTDOCEOS.m-1,75135.020-50-51,050I
11/2/17 17:54
10/31/17
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsCoric VladCTDOCEOS.m-4,41229.410-150-21575I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact